COVID-19 Vaccine Study in Cancer Patients

Dana-Farber researchers are leading a study that looks at the effects of the COVID-19 vaccine in cancer patients.

Related Presenters

Sara M. Tolaney, MD, MPH.

Sara M. Tolaney, MD, MPH

Medical Oncology

Dr. Tolaney received her undergraduate degree from Princeton University in 1998 and her medical degree from UC San Francisco in 2002. She subsequently completed her residency in Internal Medicine at Johns Hopkins University, and fellowships ...

View Full Profile

Toni Choueiri, MD.

Toni Choueiri, MD

Medical Oncology

Dr. Toni K. Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute, co-leader of the Kidney Cancer Program at Dana-Farber/Harvard Cancer Center, and the Jerome and Nancy Kohlberg Chair ...

View Full Profile


Related Videos